Saudi Pharmaceutical Journal (May 2022)

Retraction notice to “Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases” [Saudi Pharm. J. 28(12) (2020) 1655–1665]

Xue Jin,
Ling Song,
Chao-Chao Ma,
Yan-Chun Zhang,
Shui Yu

Affiliations

Xue Jin: Department of Cardiology, First Hospital of Jilin University, PR China
Ling Song: Department of Cardiology, First Hospital of Jilin University, PR China
Chao-Chao Ma: Department of Cardiology, First Hospital of Jilin University, PR China
Yan-Chun Zhang: Department of Cardiology, First Hospital of Jilin University, PR China
Shui Yu: Department of Cardiology, First Hospital of Jilin University, PR China

DOI: https://doi.org/10.1016/j.jsps.2022.04.011
Journal volume & issue: Vol. 30, no. 5
p. 646

Abstract

No abstracts available.

Published in Saudi Pharmaceutical Journal

ISSN: 1319-0164 (Print); 2213-7475 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://www.sciencedirect.com/journal/saudi-pharmaceutical-journal

About the journal